Company name Irish Stock Exchange
Headline GEM Notice


RNS Number : 9942Z
Irish Stock Exchange
20 March 2017
 

 

REPORT OF THE BOARD OF THE IRISH

STOCK EXCHANGE

 

 

 

ADMISSION NOTICE

 

                                   

Irish Stock Exchange

28 Anglesea Street

Dublin 2

 

 

20th March 2017

 

The board of the Irish Stock Exchange approves the admission of the undermentioned securities to listing on the Official List and trading on the Global Exchange Market of the ISE.

 

THERAVANCE BIOPHARMA, INC.

 

USD 230,000,000 principal amount of its 3.25% Convertible Senior Notes due 2023 US88339KAA07

 

Debt Security

 

This announcement has been issued through the Companies Announcement Service of

the Irish Stock Exchange.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEJMMFTMBBTBAR